ChromaDex Statistics
Share Statistics
ChromaDex has 77.75M
shares outstanding. The number of shares has increased by 2.93%
in one year.
Shares Outstanding | 77.75M |
Shares Change (YoY) | 2.93% |
Shares Change (QoQ) | 1.79% |
Owned by Institutions (%) | 29.49% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 222 |
FTD / Avg. Volume | 0.03% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 47.16 and the forward
PE ratio is null.
ChromaDex's PEG ratio is
-0.18.
PE Ratio | 47.16 |
Forward PE | n/a |
PS Ratio | 6.55 |
Forward PS | 3.7 |
PB Ratio | 8.75 |
P/FCF Ratio | 33.75 |
PEG Ratio | -0.18 |
Financial Ratio History Enterprise Valuation
ChromaDex has an Enterprise Value (EV) of 361.17M.
EV / Sales | 5.86 |
EV / EBITDA | 46.75 |
EV / EBIT | 29.83 |
EV / FCF | 30.23 |
Financial Position
The company has a current ratio of 3.57,
with a Debt / Equity ratio of 0.06.
Current Ratio | 3.57 |
Quick Ratio | 3.06 |
Debt / Equity | 0.06 |
Debt / EBITDA | 0.34 |
Debt / FCF | 0.22 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 18.55% and Return on Invested Capital is 14.53%.
Return on Equity | 18.55% |
Return on Assets | 12.52% |
Return on Invested Capital | 14.53% |
Revenue Per Employee | $592,173.08 |
Profits Per Employee | $82,211.54 |
Employee Count | 104 |
Asset Turnover | 0.9 |
Inventory Turnover | n/a |
Taxes
Income Tax | 305K |
Effective Tax Rate | 3.44% |
Stock Price Statistics
The stock price has increased by 131.47% in the
last 52 weeks. The beta is 2.21, so ChromaDex's
price volatility has been higher than the market average.
Beta | 2.21 |
52-Week Price Change | 131.47% |
50-Day Moving Average | 6.5 |
200-Day Moving Average | 4.98 |
Relative Strength Index (RSI) | 44.35 |
Average Volume (20 Days) | 809,373 |
Income Statement
In the last 12 months, ChromaDex had revenue of 61.59M
and earned 8.55M
in profits. Earnings per share was 0.11.
Revenue | 61.59M |
Gross Profit | 61.59M |
Operating Income | 7.73M |
Net Income | 8.55M |
EBITDA | 7.73M |
EBIT | 7.73M |
Earnings Per Share (EPS) | 0.11 |
Full Income Statement Balance Sheet
The company has 44.66M in cash and 2.65M in
debt, giving a net cash position of 42.01M.
Cash & Cash Equivalents | 44.66M |
Total Debt | 2.65M |
Net Cash | 42.01M |
Retained Earnings | -181.91M |
Total Assets | 66.19M |
Working Capital | 46.15M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 12.11M
and capital expenditures -163K, giving a free cash flow of 11.95M.
Operating Cash Flow | 12.11M |
Capital Expenditures | -163K |
Free Cash Flow | 11.95M |
FCF Per Share | 0.16 |
Full Cash Flow Statement Margins
Gross margin is 100%, with operating and profit margins of 12.55% and 13.88%.
Gross Margin | 100% |
Operating Margin | 12.55% |
Pretax Margin | 14.38% |
Profit Margin | 13.88% |
EBITDA Margin | 12.55% |
EBIT Margin | 12.55% |
FCF Margin | 19.4% |
Dividends & Yields
CDXC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 2.12% |
FCF Yield | 2.96% |
Dividend Details Analyst Forecast
The average price target for CDXC is $8.1,
which is 2.9% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.1 |
Price Target Difference | 2.9% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on Apr 13, 2016. It was a
backward
split with a ratio of 1:3.
Last Split Date | Apr 13, 2016 |
Split Type | backward |
Split Ratio | 1:3 |
Scores
Altman Z-Score | 20.97 |
Piotroski F-Score | 7 |